What they are saying: Intellectual property protections are critical as we work to defeat COVID-19

The U.S. biopharmaceutical industry depends on reliable intellectual property (IP) protections to promote the development of new breakthrough treatments and cures for patients. Strong IP protections are especially important while biopharmaceutical companies work around the clock to develop solutions to help prevent infection and treat those with COVID-19, a disease cause by the novel strain of coronavirus. In fact, many of the existing medicines and investigational medicines being tested for COVID-19 exist today because of IP and other incentives that drove their research and development.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Intellectual Property IP Explained Coronavirus Source Type: news